• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症内在的趋化因子Cxcl5在三维空间中协调全局代谢重编程以抵抗氧化性细胞死亡。

Cancer-intrinsic Cxcl5 orchestrates a global metabolic reprogramming for resistance to oxidative cell death in 3D.

作者信息

Seo Ramin, de Guzman Arvie Camille V, Park Sunghyouk, Lee Ji Youn, Kang Suk-Jo

机构信息

Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.

College of Pharmacy, Natural Product Research Institute, Seoul National University, Seoul, 08826, Republic of Korea.

出版信息

Cell Death Differ. 2025 Mar 7. doi: 10.1038/s41418-025-01466-y.

DOI:10.1038/s41418-025-01466-y
PMID:40050422
Abstract

Pancreatic ductal adenocarcinoma is characterized by a three-dimensional (3D) tumor microenvironment devoid of oxygen and nutrients but enriched in extracellular matrix, which acts as a physical and chemical barrier. In 3D, cancer cells reprogram their metabolic pathways in ways that help them survive hostile conditions. However, little is known about the metabolic phenotypes of cancer cells in 3D and the intrinsic cues that modulate them. We found that Cxcl5 deletion restricted pancreatic tumor growth in a 3D spheroid-in-Matrigel culture system without affecting cancer cell growth in 2D culture. Cxcl5 deletion impaired 3D-specific global metabolic reprogramming, resistance to hypoxia-induced cell death, and upregulation of Hif1α and Myc. Overexpression of Hif1α and Myc, however, effectively restored 3D culture-induced metabolic reconfiguration, growth, redox homeostasis, and mitochondrial function in Cxcl5 cells, reducing ferroptosis. We also found that pancreatic cancer patients with higher expression of hypoxia and metabolism-related genes whose expression is well-correlated with CXCL5 generally have poorer prognosis. Together, our findings identify an unanticipated role of Cxcl5 in orchestrating the cancer metabolic reprogramming in 3D culture that is required for energy and biomass maintenance and that restricts oxidative cell death. Thus, our results provide a rationale for targeting CXCL5 as a promising therapeutic strategy.

摘要

胰腺导管腺癌的特征是三维(3D)肿瘤微环境,其中缺乏氧气和营养物质,但富含细胞外基质,细胞外基质起到物理和化学屏障的作用。在三维环境中,癌细胞以有助于它们在恶劣条件下存活的方式重新编程其代谢途径。然而,对于三维环境中癌细胞的代谢表型以及调节它们的内在线索知之甚少。我们发现,在基质胶中培养的3D球体培养系统中,Cxcl5缺失会限制胰腺肿瘤生长,而不影响二维培养中的癌细胞生长。Cxcl5缺失会损害3D特异性的全局代谢重编程、对缺氧诱导的细胞死亡的抗性以及Hif1α和Myc的上调。然而,Hif1α和Myc的过表达有效地恢复了Cxcl5细胞中3D培养诱导的代谢重配置、生长、氧化还原稳态和线粒体功能,减少了铁死亡。我们还发现,缺氧和代谢相关基因表达较高且与CXCL5表达高度相关的胰腺癌患者通常预后较差。总之,我们的研究结果确定了Cxcl5在协调3D培养中的癌症代谢重编程方面的意外作用,这种重编程是维持能量和生物量所必需的,并且限制了氧化性细胞死亡。因此,我们的结果为将CXCL5作为一种有前景的治疗策略提供了理论依据。

相似文献

1
Cancer-intrinsic Cxcl5 orchestrates a global metabolic reprogramming for resistance to oxidative cell death in 3D.癌症内在的趋化因子Cxcl5在三维空间中协调全局代谢重编程以抵抗氧化性细胞死亡。
Cell Death Differ. 2025 Mar 7. doi: 10.1038/s41418-025-01466-y.
2
The Key Role of COA6 in Pancreatic Ductal Adenocarcinoma: Metabolic Reprogramming and Regulation of the Immune Microenvironment.COA6在胰腺导管腺癌中的关键作用:代谢重编程与免疫微环境调节
J Cell Mol Med. 2025 Jul;29(13):e70685. doi: 10.1111/jcmm.70685.
3
TYROBP overexpression alters macrophage phenotype and enhances pancreatic cancer stemness through STAT3 and PKM2 signaling.TYROBP过表达通过STAT3和PKM2信号通路改变巨噬细胞表型并增强胰腺癌干性。
Cell Signal. 2025 Jun 17:111949. doi: 10.1016/j.cellsig.2025.111949.
4
PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC.PLAGL2作为胰腺癌的一种预后生物标志物和上皮-间质转化促进因子。
Sci Rep. 2025 Jul 14;15(1):25425. doi: 10.1038/s41598-025-09591-x.
5
Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models.耐药性胰腺癌细胞在 3D 共培养模型的影像学研究中与基质成纤维细胞表现出不同的生物物理相互作用。
Sci Rep. 2024 Sep 5;14(1):20698. doi: 10.1038/s41598-024-71372-9.
6
eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment.真核生物延伸因子2激酶(eEF2K)是胰腺癌中一个预后不良的因素和新的分子靶点:通过肿瘤微环境调节肿瘤生长和进展。
Cell Death Dis. 2025 Jul 7;16(1):501. doi: 10.1038/s41419-025-07803-w.
7
The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice.胰腺癌进展中的I型胶原蛋白悖论:微环境保护者变成肿瘤帮凶。
J Transl Med. 2025 Jul 4;23(1):744. doi: 10.1186/s12967-025-06778-8.
8
Ferroptosis-related LINC02535/has-miR-30c-5p/EIF2S1 axis as a novel prognostic biomarker involved in immune infiltration and progression of PDAC.铁死亡相关 LINC02535/has-miR-30c-5p/EIF2S1 轴作为一种新的预后生物标志物,参与 PDAC 的免疫浸润和进展。
Cell Signal. 2024 Nov;123:111338. doi: 10.1016/j.cellsig.2024.111338. Epub 2024 Aug 6.
9
In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency.体内 CRISPR 筛选鉴定出香叶基二磷酸为胰腺癌肿瘤生长的依赖性物质。
Mol Metab. 2024 Jul;85:101964. doi: 10.1016/j.molmet.2024.101964. Epub 2024 May 31.
10
HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer.HSP70 介导的线粒体动态和自噬代表了胰腺癌的一个新的脆弱性。
Cell Death Differ. 2024 Jul;31(7):881-896. doi: 10.1038/s41418-024-01310-9. Epub 2024 May 28.

本文引用的文献

1
Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.解析肿瘤微环境:洞察癌症转移和治疗策略。
Cancer Lett. 2024 Jun 1;591:216894. doi: 10.1016/j.canlet.2024.216894. Epub 2024 Apr 16.
2
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions.铁死亡在癌症中的作用:肿瘤抑制、肿瘤微环境和治疗干预。
Cancer Cell. 2024 Apr 8;42(4):513-534. doi: 10.1016/j.ccell.2024.03.011.
3
Crosstalk between metabolism and cell death in tumorigenesis.
肿瘤发生过程中代谢与细胞死亡的串扰。
Mol Cancer. 2024 Apr 4;23(1):71. doi: 10.1186/s12943-024-01977-1.
4
Mechanosensing regulates tissue repair program in macrophages.机械感知调节巨噬细胞中的组织修复程序。
Sci Adv. 2024 Mar 15;10(11):eadk6906. doi: 10.1126/sciadv.adk6906. Epub 2024 Mar 13.
5
Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond.肿瘤中的代谢性细胞死亡:铁死亡、铜死亡、二硫键依赖的细胞死亡及其他。
Protein Cell. 2024 Sep 1;15(9):642-660. doi: 10.1093/procel/pwae003.
6
The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies.非编码 RNA 对 HIF-1α 的严格调控:增殖、转移和治疗抵抗策略的新见解。
Cancer Metastasis Rev. 2024 Mar;43(1):5-27. doi: 10.1007/s10555-023-10129-8. Epub 2023 Aug 8.
7
Pancreatic cancer: Advances and challenges.胰腺癌:进展与挑战。
Cell. 2023 Apr 13;186(8):1729-1754. doi: 10.1016/j.cell.2023.02.014.
8
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.不断演变的肿瘤微环境:从癌症起始到转移灶生长
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
9
CXCL5: A coachman to drive cancer progression.CXCL5:驱动癌症进展的“车夫”
Front Oncol. 2022 Aug 1;12:944494. doi: 10.3389/fonc.2022.944494. eCollection 2022.
10
Macrophages as tools and targets in cancer therapy.巨噬细胞作为癌症治疗的工具和靶点。
Nat Rev Drug Discov. 2022 Nov;21(11):799-820. doi: 10.1038/s41573-022-00520-5. Epub 2022 Aug 16.